Colorectal cancer is one of the deadliest but most preventable causes of death in the United States. The American Gastroenterological Association (AGA) Institute supports clinically proven technologies that increase the number of patients who are screened for the disease.
The results of a county-wide survey released by the Monroe County Department of Public Health show that obesity and associated health problems – diabetes and hypertension – remain a growing public health threat. At the same time, the survey confirms that interventions and public awareness campaigns in areas such as smoking, vaccinations, and colon cancer screening have produced positive results.
New research has yielded a clearer picture of which biomarkers could help doctors more precisely target the treatment of colon cancer, bringing closer the day when patients who will not benefit from chemotherapy are spared it, while those that will, get the more aggressive treatment they need.
A new version of a colon cancer screening test effectively detects colorectal cancer and may be a good replacement for the test that is currently used, according to a study in the Sept. 25 Journal of the National Cancer Institute.
Eating fruits and vegetables was not strongly associated with decreased colon cancer risk, according to a study published online in the Sept. 25 Journal of the National Cancer Institute.
An under-used colon cancer screening test now available in the U.S. effectively detects colorectal cancer and may help to improve colon cancer screening rates, according to investigators at the Kaiser Permanente Division of Research. The study appears in the September 25, 2007 issue of the Journal of the National Cancer Institute (JNCI).
Italian scientists will announce today (Monday September 24) that they have found a new and promising target for anti-tumour therapy in cancer. Professor Saverio Alberti, from the CESI, University of Chieti Foundation, Chieti, will tell the European Cancer Conference (ECCO 14) that he and his team have found a widespread mechanism for the stimulation of tumour growth in man, and that this is leading to the development of novel diagnostic and therapeutic procedures.
One of the best ways to encourage an individual to get screened for colorectal cancer is to use a personalized approach, according to researchers at Jefferson Medical College in Philadelphia. A new study shows that simple, personalized interventions that guide recipients through the screening process can significantly improve colorectal cancer screening rates in primary care practices.
Research here shows that an obscure form of RNA, part of the protein-making machinery in all cells, might play an important role in human cancer. These ultraconserved non-coding RNAs (UCRs) have been considered ?junk? by some researchers, but a new report in the September issue of the journal Cancer Cell indicates that this may not be the case.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.